Back to Agenda
Global Pharmacovigilance and Risk Management in 2020
Session Chair(s)
Mick Foy
Director of Delivery
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
The session will look beyond our current systems and requirements and consider the big opportunities and challenges for pharmacovigilance over the next 10 years. Global experts from inside and outside the EU will offer their perspectives on key issues and future developments through an interactive panel discussion.
Speaker(s)
Panel Discussion
June Raine, MD, MSc, FRCP
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Chief Executive
Panel Discussion
Gerald Dal Pan, MD, MHS
FDA, United States
Director, Office of Surveillance and Epidemiology, CDER
Panel Discussion
Munir Pirmohamed, PhD
Royal Liverpool University Hospital, United Kingdom
David Weatherall Chair in Medicine, Consultant Physician
Panel Discussion
Steve Hobbiger
GlaxoSmithKline , United Kingdom
Senior Vice President and QPPV, R&D
Panel Discussion
Sabine Brosch, PharmD, PhD, MPharm
European Medicines Agency, Netherlands
Data Protection Officer
Bettina Ryll
MPNE, Vision Zero Cancer, Sweden
Member of the First EU Cancer Mission Board
Have an account?